financetom
Business
financetom
/
Business
/
What's Going On With Cingulate Shares Recently?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Cingulate Shares Recently?
Sep 1, 2024 11:40 AM

Cingulate Inc. ( CING ) shares are soaring Friday.

Last week, the company announced a Precision Timed Release (PTR) technology, designed to enhance ADHD drug delivery. The company’s technology aims to improve the onset and efficacy of existing ADHD treatments. Zacks Small-Cap Research also issued a note with a $70 valuation on the stock earlier this week.

Trading Volume: The stock opened at $6.63 and has traded within a day range of $6.01 to $9.69. The 50-day moving average stands at $5.81. Cingulate’s short interest has decreased by 75.73% since its last report, now at 51,000 shares, which is 3.18% of its float.

Key Metrics Recap:

Market Cap (Previous Close): $11.12 million

52-Week Range: $1.80 – $187.2

Float: 1.622 million shares

Institutional Ownership: 1.13%

Insider Ownership: 14.27%

How To Buy CING Stock?

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the the case of Cingulate ( CING ) , which is trading at $8.2 as of publishing time, $100 would buy you 12.2 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

CING Price Action: Cingulate ( CING ) shares were up by 15% at $7.42 according to Benzinga pro.

See Also:

Wall Street Analysts Believe XPEL Could Rally 49.46%: Here’s is How to Trade

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sage Therapeutics Drug's Failure in Huntington's 'Not Surprising,' RBC Says
Sage Therapeutics Drug's Failure in Huntington's 'Not Surprising,' RBC Says
Nov 21, 2024
03:16 PM EST, 11/21/2024 (MT Newswires) -- Sage Therapeutics ( SAGE ) drug's failure in Huntington's disease was not surprising as there was a low likelihood of success to begin with, RBC Capital Markets said in a note emailed Thursday. RBC was referring to Sage's dalzanemdor, which failed to meet the main and secondary goals in a phase 2 study...
--BancFirst Keeps Quarterly Dividend at $0.46 a Share, Payable Jan. 15 to Shareholders as of Dec. 31
--BancFirst Keeps Quarterly Dividend at $0.46 a Share, Payable Jan. 15 to Shareholders as of Dec. 31
Nov 21, 2024
03:39 PM EST, 11/21/2024 (MT Newswires) -- Price: 123.21, Change: +2.00, Percent Change: +1.65 ...
D R Horton Insider Sold Shares Worth $921,515, According to a Recent SEC Filing
D R Horton Insider Sold Shares Worth $921,515, According to a Recent SEC Filing
Nov 21, 2024
03:36 PM EST, 11/21/2024 (MT Newswires) -- Barbara K Allen, Director, on November 21, 2024, sold 5,650 shares in D R Horton (DHI) for $921,515. SEC Filing: https://www.sec.gov/Archives/edgar/data/882184/000106299324019486/xslF345X05/form4.xml Price: 161.95, Change: -1.17, Percent Change: -0.72 ...
Alphabet's Google Says DOJ Proposals to Restore Online Search Competition Would 'Harm' Consumers
Alphabet's Google Says DOJ Proposals to Restore Online Search Competition Would 'Harm' Consumers
Nov 21, 2024
03:39 PM EST, 11/21/2024 (MT Newswires) -- Alphabet's (GOOG, GOOGL) Google ( GOOG ) unit said Thursday that the US Department of Justice's latest proposals, including pushing the company to sell the Chrome web browser, would harm consumers. In August, a federal judge ruled that the company operated an illegal monopoly and violated US antitrust laws by spending tens of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved